Published online Nov 26, 2016. doi: 10.4330/wjc.v8.i11.657
Peer-review started: June 4, 2016
First decision: July 5, 2016
Revised: July 21, 2016
Accepted: September 21, 2016
Article in press: September 22, 2016
Published online: November 26, 2016
Processing time: 174 Days and 22.4 Hours
To describe our experience with shock testing for the evaluation of patients with Riata™ leads.
Among 51 patients with normal baseline electrical parameters, 20 died during follow-up. Of the remaining 31 patients, 15 underwent the test: In 10 cases a defibrillation testing with ventricular fibrillation (VF) induction and in 5 cases a R-wave-synchronized shock (> 20 J, without inducing VF). The test was performed under sedation with Midazolam.
Twelve patients (80%) had a normal behavior during shock testing: In 8 cases induced VF was correctly detected and treated; in 4 cases of R-wave-synchronized shock electrical parameters remained stable and normal. Three patients (20%) failed the test. One patient with externalized conductors showed a sudden drop of high-voltage impedance (< 10 Ohm) after a 25 J R-wave-synchronized shock. Two other patients with externalized conductors, undergoing defibrillation testing, showed a short-circuit during shock delivery and the implantable cardioverter defibrillator was unable to interrupt VF.
In Riata™ leads the delivery of a low current during routine measurement of high-voltage impedance may not reveal a small short circuit, that can only be evident by attempting to deliver a true shock, either for spontaneous arrhythmias or in the context of a shock testing.
Core tip: The management of Riata™ defibrillator leads is complex and optimal treatment is often carried out on individual basis. These leads are prone to a unique failure mechanism: The conductors can externalize through the silicone insulation (“inside-out” abrasion) and appear outside the lead body leading to electrical failure. The potential role of high-voltage shock testing for these leads has been poorly studied, only sparse reports being available. In Riata™ leads the delivery of a low current during routine measurement of high-voltage impedance may not reveal a small short circuit, that can only be evident by attempting to deliver a true shock, either for spontaneous arrhythmias or in the context of a shock testing. Defibrillation testing (or alternatively synchronized shock) should be considered an important tool to check Riata™ integrity.